As of 2025-05-24, the Relative Valuation of Mesa Laboratories Inc (MLAB) is (1,525.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 109.85 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -1488.4%.
The range of the Relative Valuation is (1,456.23) - (1,561.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.2x - 37.3x | 33.8x |
| Forward P/E multiples | 31.7x - 34.0x | 32.7x |
| Fair Price | (1,456.23) - (1,561.89) | (1,525.14) |
| Upside | -1425.7% - -1521.8% | -1488.4% |
| Date | P/E |
| 2025-05-22 | -2.42 |
| 2025-05-21 | -2.44 |
| 2025-05-20 | -2.51 |
| 2025-05-19 | -2.58 |
| 2025-05-16 | -2.66 |
| 2025-05-15 | -2.64 |
| 2025-05-14 | -2.61 |
| 2025-05-13 | -2.76 |
| 2025-05-12 | -2.79 |
| 2025-05-09 | -2.70 |
| 2025-05-08 | -2.73 |
| 2025-05-07 | -2.62 |
| 2025-05-06 | -2.57 |
| 2025-05-05 | -2.58 |
| 2025-05-02 | -2.59 |
| 2025-05-01 | -2.51 |
| 2025-04-30 | -2.51 |
| 2025-04-29 | -2.55 |
| 2025-04-28 | -2.55 |
| 2025-04-25 | -2.54 |
| 2025-04-24 | -2.53 |
| 2025-04-23 | -2.49 |
| 2025-04-22 | -2.46 |
| 2025-04-21 | -2.37 |
| 2025-04-17 | -2.44 |
| 2025-04-16 | -2.46 |
| 2025-04-15 | -2.51 |
| 2025-04-14 | -2.48 |
| 2025-04-11 | -2.49 |
| 2025-04-10 | -2.39 |
| 2025-04-09 | -2.55 |
| 2025-04-08 | -2.29 |
| 2025-04-07 | -2.37 |
| 2025-04-04 | -2.35 |
| 2025-04-03 | -2.36 |
| 2025-04-02 | -2.63 |
| 2025-04-01 | -2.56 |
| 2025-03-31 | -2.58 |
| 2025-03-28 | -2.60 |
| 2025-03-27 | -2.71 |
| 2025-03-26 | -2.65 |
| 2025-03-25 | -2.73 |
| 2025-03-24 | -2.80 |
| 2025-03-21 | -2.72 |
| 2025-03-20 | -2.69 |
| 2025-03-19 | -2.70 |
| 2025-03-18 | -2.75 |
| 2025-03-17 | -2.80 |
| 2025-03-14 | -2.75 |
| 2025-03-13 | -2.66 |